Ennov names Oxana Pickeral CEO
Ennov said Sept. 9, 2026, that Dr. Oxana Pickeral will become chief executive officer, replacing founder Olivier Pâris, who will move to the board and serve as strategic adviser. The life sciences compliance software company said the change supports its push into AI, North American expansion and broader global growth after a recent investment from Bregal Sagemount and Ardian.
Why it matters: - Ennov is changing leaders as it pushes deeper into AI-enabled compliance software for life sciences and healthcare customers. - The CEO shift comes alongside plans to expand in North America and grow commercial operations in Europe and Asia. - The move follows a recent investment from Bregal Sagemount, with participation from Ardian, which adds capital and backers with experience scaling healthcare technology companies.
What happened: - Ennov appointed Dr. Oxana Pickeral as chief executive officer on Sept. 9, 2026. - Founder and outgoing CEO Olivier Pâris will join Ennov’s board of directors and remain a strategic adviser. - Ennov describes itself as a global provider of a unified compliance platform for regulatory, clinical, quality and pharmacovigilance operations.
The details: - Pickeral most recently led Honeywell’s global software and connected life sciences business. - She previously served as president and CEO of Sparta Systems, a Honeywell company. - Her background also includes work on the Human Genome Project and growth roles at Amazon Web Services’ Healthcare & Life Sciences partner business. - Ennov said Pickeral will accelerate efforts to embed AI across its unified platform. - The company said its platform is built to support agentic regulatory, quality and clinical workflows. - Ennov said the system uses a single data lake and a highly configurable architecture. - The company plans to establish a North American delivery and commercial hub. - Ennov also plans to expand its international go-to-market capabilities in Europe and Asia. - Pâris founded Ennov in 1999. - Under Pâris, Ennov grew to about 650 customers and more than 500,000 users worldwide.
Between the lines: - The leadership change signals a transition from founder-led scale-up to a phase focused on larger commercial execution and product expansion. - Pickeral’s mix of life sciences, cloud and enterprise software experience fits Ennov’s push to tie AI and workflow automation more closely to regulated industry operations. - Bregal Sagemount and Ardian appear positioned to support expansion as Ennov tries to compete more broadly across global markets.
What's next: - Ennov will look to deepen AI features across its platform under Pickeral’s leadership. - The company is expected to build out its North American presence while continuing international growth. - Pâris will remain involved through the board as Ennov moves into its next phase.
The bottom line: - Ennov is handing the CEO role to a life sciences technology veteran as it tries to scale faster, broaden its footprint and build more AI into its compliance platform.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Asia Pacific News Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.